Efficacy of carboxymethylcellulose and hyaluronate in dry eye disease: A systematic review and meta-analysis

Korean Journal of Family Medicine

Volumn 38, Issue 1, 2017, Pages 2-7

  Song, Jae Kyeong ^a   Lee, Kiheon ^b   Park, Hwa Yeon ^b   Hyon, Joon Young ^b   Oh, Seung Won ^c   Bae, Woo Kyung ^b   Han, Jong Soo ^b   Jung, Se Young ^b   Um, Yoo Jin ^b   Lee, Ga Hye ^a   Yang, Ji Hye ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

Author keywords

Carboxymethylcellulose sodium; Fluorescein tear breakup time; Hyaluronate; Xerophthalmia

Indexed keywords

EID: 85013041944     PISSN: 20056443     EISSN: 20926715     Source Type: Journal    
DOI: 10.4082/kjfm.2017.38.1.2     Document Type: Article

References (22)

1. Baudouin C. The pathology of dry eye. Surv Ophthalmol 2001;45 Suppl 2:S211-20.
2. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21:221-32.
3. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:75-92.
4. Johnson ME, Murphy PJ. Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res 2004;23:449-74.
5. Aragona P, Papa V, Micali A, Santocono M, Milazzo G. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 2002;86:181-4.
6. Lee JH, Ahn HS, Kim EK, Kim TI. Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease. Cornea 2011;30:175-9.
7. Hunt G, Kearney P, Kellaway I. Mucoadhesive polymers in drug delivery systems. In: Johnson P, Lloyd-Jones JG; Society for Drug Research, editors. Drug delivery systems: fundamentals and techniques. Chichester: Ellis Horwood; 1987. p. 180-99.
8. Peppas NA, Buri PA. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Release 1985;2:257-75.
9. Meyer K. Chemical structure of hyaluronic acid. Fed Proc 1958;17:1075-7.
10. Nakamura M, Hikida M, Nakano T, Ito S, Hamano T, Kinoshita S. Characterization of water retentive properties of hyaluronan. Cornea 1993;12:433-6.
11. Baudouin C, Cochener B, Pisella PJ, Girard B, Pouliquen P, Cooper H, et al. Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease. Eur J Ophthalmol 2012;22:751-61.
12. Benelli U, Nardi M, Posarelli C, Albert TG. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness. Cont Lens Anterior Eye 2010;33:61-7.
13. Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudouin C. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Graefes Arch Clin Exp Ophthalmol 2005;243:531-8.
14. Mencucci R, Boccalini C, Caputo R, Favuzza E. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery. J Cataract Refract Surg 2015;41:1699-704.
15. Sanchez MA, Torralbo-Jimenez P, Giron N, de la Heras B, Herrero Vanrell R, Arriola-Villalobos P, et al. Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study. Cornea 2010;29:167-71.
16. Simmons PA, Liu H, Carlisle-Wilcox C, Vehige JG. Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial. Clin Ophthalmol 2015;9:665-75.
17. NCT00938704. Study to compare the efficacy and safety of two nonpreserved artificial tears for the treatment of dry eye signs and symptoms [Internet]. Bethesda (MD): National Institutes of Health; 2011 [cited 2016 Feb 14]. Available from: https://clinicaltrials.gov/ct2/show/NCT00938704.
18. NCT00987727. Safety and efficacy of carboxymethylcellulose for ocular surface integrity in symptomatic dry eye [Internet]. Bethesda (MD): National Institutes of Health; 2011 [cited 2016 Feb 14]. Available from: https://clinicaltrials.gov/ct2/show/NCT00987727?term=NCT00987727 &rank=1.
19. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.
20. Hedges LV, Olkin I. Statistical methods for meta-analysis. Orlando (FL): Academic Press; 1985.
21. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [Internet]. London: The Cochrane Collaboration; 2011 [cited 2016 Feb 14]. Available from: http://handbook. cochrane.org/.
22. Furrer P, Mayer JM, Gurny R. Ocular tolerance of preservatives and alternatives. Eur J Pharm Biopharm 2002;53:263-80.